<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Rare Disease | CSE Tracker</title>
    <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20201102rare-disease/</link>
      <atom:link href="https://master--youthful-lamport-190a0e.netlify.app/tag/20201102rare-disease/index.xml" rel="self" type="application/rss+xml" />
    <description>Rare Disease</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Mon, 02 Nov 2020 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://master--youthful-lamport-190a0e.netlify.app/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>Rare Disease</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20201102rare-disease/</link>
    </image>
    
    <item>
      <title>2020 New England Rare Disease Statistics (NERDS) Webinar Series</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/202011022020-new-england-rare-disease-statistics-nerds-webinar-series/</link>
      <pubDate>Mon, 02 Nov 2020 00:00:00 +0000</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/202011022020-new-england-rare-disease-statistics-nerds-webinar-series/</guid>
      <description>&lt;p&gt;&lt;strong&gt;1. Introductory NERDS Session&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;
&lt;p&gt;How to Select Endpoints and Quantify Treatment Effect in a Comparative Clinical Study on COVID-19 Diseases (L.J. Wei (Harvard))&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;Borrowing Information from Historical Data: A Double-edged Sword (Ying Yuan (MD Anderson))&lt;/p&gt;
&lt;/li&gt;
&lt;li&gt;
&lt;p&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=13985dd6a939e0e4f8998620b4a428b1&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: hWFURkY5)&lt;/p&gt;
&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;2. CID Program Update&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;A Bayesian Adaptive Trial in Duchenne Muscular Dystrophy (Steve Lake (Wave Life Sciences))&lt;/li&gt;
&lt;li&gt;Innovative Designs in the Rare Disease Setting (Dionne Price (FDA))&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=1bc6e1d02b1002d62c170a17473e3d54&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: pMbpsJT7)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;3. Gene Therapy in Rare Disease Development&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Gene Therapy: Opportunities and Challenges for the Treatment of Hemophilia (Michelle Casey (Pfizer))&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=ccaaeefdd89e63e72892e9650397f117&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: NERDS456)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;4. Case Studies in Rare Disease Drug Development&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Lessons from Notable New Drug Application involving External Controls (Margaret (Meg) Gamalo (Pfizer))&lt;/li&gt;
&lt;li&gt;Design and Analysis of Drop the Losers Studies in the Rare Disease Setting (Glen Laird (Vertex))&lt;/li&gt;
&lt;li&gt;A Case Study Using Nature History Data to Understand Long Term Disease Progression (Cindy Lu (Biogen))&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://pfizerevents.webex.com/pfizerevents/lsr.php?RCID=e227bbfd8699459593dffc5ce07cd795&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;Recording&lt;/a&gt; (Password: Pq8pBWgU)&lt;/li&gt;
&lt;/ul&gt;</description>
    </item>
    
  </channel>
</rss>
